Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese Generic Drug Makers Report Profits

This article was originally published in PharmAsia News

Executive Summary

Major Japanese generic drugs makers Sawai, Towa Yakuhin and Taiyo Yakuhin reported strong third-quarter fiscal results. Sawai achieved double digit increase in both sales and profit (PharmAsia News Feb.12 2009); Towa's sales grew by 13.7 percent to ¥26.6 billion and net profit increased by 6.7 percent to ¥2.5 billion. The company also revised upward for full year estimated sales. Taiyo's sales increased by 13.4 percent to ¥31.9 billion and ordinary profit increased by 14.2 percent to ¥6.1 billion. The growth is a result of the government's generic drug promotion measures. (Click here for more - Japanese language
Advertisement

Related Content

Sawai Pharmaceutical Achieves Double Digit Growth In Sales And Profits
Advertisement
UsernamePublicRestriction

Register

SC070795

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel